Chemoinformaics analysis of 2-(2,2-Dimethylhydrazino)-4-(5-nitro-2-furyl)thiazole
Molecular Weight | 254.271 | nRot | 4 |
Heavy Atom Molecular Weight | 244.191 | nRig | 6 |
Exact Molecular Weight | 254.047 | nRing | 2 |
Solubility: LogS | -3.927 | nHRing | 2 |
Solubility: LogP | 3.764 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 4 | No. of Arom Atom | 10 |
No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
nHA | 7 | APOL | 31.4039 |
nHD | 1 | BPOL | 17.6741 |
QED | 0.586 |
Synth | 2.453 |
Natural Product Likeliness | 1.484 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.827 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.552 |
MDCK | 0.0000202 |
BBB | 0.699 |
PPB | 0.9201 |
VDSS | 0.663 |
FU | 0.109569 |
CYP1A2-inh | 0.909 |
CYP1A2-sub | 0.938 |
CYP2c19-inh | 0.714 |
CYP2c19-sub | 0.56 |
CYP2c9-inh | 0.379 |
CYP2c9-sub | 0.668 |
CYP2d6-inh | 0.599 |
CYP2d6-sub | 0.336 |
CYP3a4-inh | 0.072 |
CYP3a4-sub | 0.27 |
CL | 6.049 |
T12 | 0.572 |
hERG | 0.019 |
Ames | 0.028 |
ROA | 0.316 |
SkinSen | 0.632 |
Carcinogencity | 0.438 |
EI | 0.961 |
Respiratory | 0.864 |
NR-Aromatase | 0.037 |
Antiviral | No |
Prediction | 0.749821 |